These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
153 related articles for article (PubMed ID: 31917867)
1. Complexities in the medical management of hypoglycaemia due to congenital hyperinsulinism. Worth C; Yau D; Salomon Estebanez M; O'Shea E; Cosgrove K; Dunne M; Banerjee I Clin Endocrinol (Oxf); 2020 May; 92(5):387-395. PubMed ID: 31917867 [TBL] [Abstract][Full Text] [Related]
2. Characterization of diabetes following pancreatic surgery in patients with congenital hyperinsulinism. Welters A; Meissner T; Grulich-Henn J; Fröhlich-Reiterer E; Warncke K; Mohnike K; Blankenstein O; Menzel U; Datz N; Bollow E; Holl RW Orphanet J Rare Dis; 2018 Dec; 13(1):230. PubMed ID: 30577875 [TBL] [Abstract][Full Text] [Related]
3. Standardised practices in the networked management of congenital hyperinsulinism: a UK national collaborative consensus. Shaikh MG; Lucas-Herald AK; Dastamani A; Salomon Estebanez M; Senniappan S; Abid N; Ahmad S; Alexander S; Avatapalle B; Awan N; Blair H; Boyle R; Chesover A; Cochrane B; Craigie R; Cunjamalay A; Dearman S; De Coppi P; Erlandson-Parry K; Flanagan SE; Gilbert C; Gilligan N; Hall C; Houghton J; Kapoor R; McDevitt H; Mohamed Z; Morgan K; Nicholson J; Nikiforovski A; O'Shea E; Shah P; Wilson K; Worth C; Worthington S; Banerjee I Front Endocrinol (Lausanne); 2023; 14():1231043. PubMed ID: 38027197 [TBL] [Abstract][Full Text] [Related]
4. Congenital hyperinsulinism in infancy and childhood: challenges, unmet needs and the perspective of patients and families. Banerjee I; Raskin J; Arnoux JB; De Leon DD; Weinzimer SA; Hammer M; Kendall DM; Thornton PS Orphanet J Rare Dis; 2022 Feb; 17(1):61. PubMed ID: 35183224 [TBL] [Abstract][Full Text] [Related]
5. Treatment with long-acting lanreotide autogel in early infancy in patients with severe neonatal hyperinsulinism. Corda H; Kummer S; Welters A; Teig N; Klee D; Mayatepek E; Meissner T Orphanet J Rare Dis; 2017 Jun; 12(1):108. PubMed ID: 28576129 [TBL] [Abstract][Full Text] [Related]
6. Conservatively treated Congenital Hyperinsulinism (CHI) due to K-ATP channel gene mutations: reducing severity over time. Salomon-Estebanez M; Flanagan SE; Ellard S; Rigby L; Bowden L; Mohamed Z; Nicholson J; Skae M; Hall C; Craigie R; Padidela R; Murphy N; Randell T; Cosgrove KE; Dunne MJ; Banerjee I Orphanet J Rare Dis; 2016 Dec; 11(1):163. PubMed ID: 27908292 [TBL] [Abstract][Full Text] [Related]
7. Ketotic hypoglycaemia in children with diazoxide responsive hyperinsulinism of infancy. Hussain K Eur J Pediatr; 2005 Jun; 164(6):387-90. PubMed ID: 15772812 [TBL] [Abstract][Full Text] [Related]
8. Efficacy of Dose-Titrated Glucagon Infusions in the Management of Congenital Hyperinsulinism: A Case Series. Salomon-Estebanez M; Yau D; Dunne MJ; Worth C; Birch S; Walewski JL; Banerjee I Front Endocrinol (Lausanne); 2020; 11():441. PubMed ID: 33013678 [No Abstract] [Full Text] [Related]
9. Drug-induced hepatitis following use of octreotide for long-term treatment of congenital hyperinsulinism. Avatapalle B; Padidela R; Randell T; Banerjee I BMJ Case Rep; 2012 Jul; 2012():. PubMed ID: 22850563 [TBL] [Abstract][Full Text] [Related]
10. Congenital hyperinsulinism: management and outcome, a single tertiary centre experience. El Tonbary K; Robinson P; Banerjee I; Shaikh MG Eur J Pediatr; 2020 Jun; 179(6):947-952. PubMed ID: 32002613 [TBL] [Abstract][Full Text] [Related]
11. Extreme caution on the use of sirolimus for the congenital hyperinsulinism in infancy patient. Banerjee I; De Leon D; Dunne MJ Orphanet J Rare Dis; 2017 Apr; 12(1):70. PubMed ID: 28410602 [TBL] [Abstract][Full Text] [Related]
13. A Multicenter Experience with Long-Acting Somatostatin Analogues in Patients with Congenital Hyperinsulinism. van der Steen I; van Albada ME; Mohnike K; Christesen HT; Empting S; Salomon-Estebanez M; Greve Rasmussen A; Verrijn Stuart A; van der Linde AAA; Banerjee I; Boot AM Horm Res Paediatr; 2018; 89(2):82-89. PubMed ID: 29241206 [TBL] [Abstract][Full Text] [Related]
14. Nifedipine in Congenital Hyperinsulinism - A Case Report. Khawash P; Hussain K; Flanagan SE; Chatterjee S; Basak D J Clin Res Pediatr Endocrinol; 2015 Jun; 7(2):151-4. PubMed ID: 26316440 [TBL] [Abstract][Full Text] [Related]
16. Investigation and management of congenital hyperinsulinism. Gilbert C Br J Nurs; 2009 Nov 26-Dec 9; 18(21):1306-10. PubMed ID: 20081678 [TBL] [Abstract][Full Text] [Related]
17. Somatostatin receptors in congenital hyperinsulinism: Biology to bedside. van Albada ME; Mohnike K; Dunne MJ; Banerjee I; Betz SF Front Endocrinol (Lausanne); 2022; 13():921357. PubMed ID: 36237195 [TBL] [Abstract][Full Text] [Related]
18. The Use of a Long-Acting Somatostatin Analogue (Lanreotide) in Three Children with Focal Forms of Congenital Hyperinsulinaemic Hypoglycaemia. Dastamani A; Güemes M; Pitfield C; Morgan K; Rajab M; Rottenburger C; Bomanji J; De Coppi P; Dattani M; Shah P Horm Res Paediatr; 2019; 91(1):56-61. PubMed ID: 30114684 [TBL] [Abstract][Full Text] [Related]
19. The Diagnosis and Management of Hyperinsulinaemic Hypoglycaemia. Roženková K; Güemes M; Shah P; Hussain K J Clin Res Pediatr Endocrinol; 2015 Jun; 7(2):86-97. PubMed ID: 26316429 [TBL] [Abstract][Full Text] [Related]
20. Clinical and genetic characteristics of patients with congenital hyperinsulinism in 21 non-consanguineous families from Serbia. Raicevic M; Milenkovic T; Hussain K; Djordjevic M; Martic J; Todorovic S; Mitrovic K; Sarajlija A; Vukovic R Eur J Pediatr; 2021 Sep; 180(9):2815-2821. PubMed ID: 33770274 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]